CD4+/CD8+ T-Cell Ratio Predictive of Surgical Margins in the Treatment of Nonmelanoma Skin Cancer Treated With Mohs Surgery of Patients Infected With the Human Immunodeficiency Virus

Skin Cancer
09/09/2020

Dermatol Surg. 2020 Sep 2. doi: 10.1097/DSS.0000000000002702. Online ahead of print.

NO ABSTRACT